BALAPADANG, R. N.; SUDARJAT, H. Potential of Beta-Hydroxybutyrate (BHB) in the Management of Type 2 Diabetes and Risk of Ketoacidosis in Diabetic Patients. Journal of Pharmaceutical and Sciences, [S. l.], v. 7, n. 4, p. 562–570, 2024. DOI: 10.36490/journal-jps.com.v7i4.520. Disponível em: https://journal-jps.com/new/index.php/jps/article/view/520. Acesso em: 21 nov. 2024.